Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6

Virology

Volumn 314, Issue 1, 2003, Pages 196-205

  Duffy, Carol L ^a   Phillips, Stacia L ^a   Klingelhutz, Aloysius J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Cornified cell envelope; Differentiation; E6 and E7 oncogenes; HPV; Human papillomavirus; Keratinocyte; Microarray; P53; Telomerase

Indexed keywords

CYTOKERATIN; ELAFIN; HUMAN PAPILLOMA VIRUS TYPE 16 E6 PROTEIN; INVOLUCRIN; ONCOPROTEIN; PROLINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN P53; UNCLASSIFIED DRUG; VIMENTIN;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; MESENCHYME; MODULATION; MUTANT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; UPREGULATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0141568874     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00390-8     Document Type: Article

References (38)

1. Alfandari J., Shnitman Magal S., Jackman A., Schlegel R., Gonen P., Sherman L. HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology. 257:(2):1999;383-396.
2. Baek S.J., Wilson L.C., Lee C.H., Eling T.E. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs) inhibition of cyclooxygenase and induction of NSAID-activated gene . J. Pharmacol. Exp. Ther. 301:(3):2002;1126-1131.
3. Brown D.R., Bryan J.T. Abnormalities of cornified cell envelopes isolated from human papillomavirus type 11-infected genital epithelium. Virology. 271:(1):2000;65-70.
4. Bieche I., Nogues C., Paradis V., Olivi M., Bedossa P., Lidereau R., Vidaud M. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin. Cancer Res. 6:2000;452-459.
5. Chang Y.E., Laimins L.A. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74:(9):2000;4174-4182.
6. Chang Y.E., Laimins L.A. Interferon-inducible genes are major targets of human papillomavirus type 31 insights from microarray analysis . Dis. Markers. 17:(3):2001;139-142.
7. Cheng S., Schmidt-Grimminger D.C., Murant T., Broker T.R., Chow L.T. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:1995;2335-2349.
8. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:(4893):1989;934-937.
9. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:(4):1993;817-825.
10. Foster S.A., Demers G.W., Etscheid B.G., Galloway D.A. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 68:(9):1994;5698-5705.
11. Gewin L., Galloway D.A. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol. 75:(15):2001;7198-7201.
12. Gilles C., Polette M., Piette J., Birembaut P., Foidart J.M. Epithelial-to-mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int. J. Cancer. 59:(5):1994;661-666.
13. Gilles C., Polette M., Piette J., Delvigne A.C., Thompson E.W., Foidart J.M., Birembaut P. Vimentin expression in cervical carcinomas association with invasive and migratory potential . J. Pathol. 180:(2):1996;175-180.
14. Harvat B.L., Wang A., Seth P., Jetten A.M. Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation. J. Cell Sci. 111:(Pt.9):1998;1185-1196.
15. Howley P.M. Role of human papillomavirus in human cancer. Cancer Res. 51:1991;5019-5022.
16. Howley P.M. Papillomavirinae the viruses and their replication . Fields B.N., Knipe D.M., Howley P.M. Fields Virology third ed. Vol. 2. 2 vols:1995;2045-2076 Lippincott Williams & Wilkins, New York.
17. Kalinin A.E., Kajava A.V., Steinert P.M. Epithelial barrier function assembly and structural features of the cornified cell envelope . Bioessays. 24:(9):2002;789-800.
18. Kaneko-Ishino T., Kuroiwa Y., Miyoshi N., Kohda T., Suzuki R., Yokoyama M., Viville S., Barton S.C., Ishino F., Surani M.A. Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat. Genet. 11:1995;52-59.
19. Klingelhutz A.J., Foster S.A., McDougall J.K. Telomerase activation by the E6 gene roduct of human papillomavirus type 16. Nature. 380:(6569):1996; 79-82.
20. Lehr E., Jarnik M., Brown D.R. Human papillomavirus type 11 alters the transcription and expression of loricrin, the major cell envelope protein. Virology. 298:(2):2002;240-247.
21. Mantovani F., Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 20:(54):2001;7874-7887.
22. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Beijersbergen R.L., Davidoff M.J., Liu Q., Bacchetti S., Haber D.A., Weinberg R.A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
23. Missero C., Di Cunto F., Kiyokawa H., Koff A., Dotto G.P. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10:(23):1996;3065-3075.
24. Munger K., Werness B.A., Dyson N., Phelps W.C., Harlow E., Howley P.M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:(13):1989;4099-4105.
25. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
26. Nees M., Geoghegan J.M., Hyman T., Frank S., Miller L., Woodworth C.D. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kB-responsive genes in cervical keratinocytes. J. Virol. 75:(9):2001; 4283-4296.
27. Nees M., Geoghegan J.M., Munson P., Prabhu V., Liu Y., Androphy E., Woodworth C.D. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Cancer Res. 60:(15):2000;4289-4298.
28. Oh S.T., Kyo S., Laimins L.A. Telomerase activation by human papillomavirus type 16 E6 protein induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites . J. Virol. 75:(12):2001;5559-5566.
29. Pim D., Banks L. HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene. 18:(52):1999;7403-7408.
30. Rapp L., Chen J. The papillomavirus E6 proteins. Biochim. Biophys. Acta. 1378:(1):1998;F1-F19.
31. Sado T., Nakajima N., Tada M., Takagi N. A novel mesoderm-specific cDNA isolated from a mouse embryonal carcinoma cell line. Dev. Growth Differ. 35:1993;551-560.
32. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:(6):1990;1129-1136.
33. Sherman L., Schlegel R. Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J. Virol. 70:(5):1996;3269-3279.
34. Veldman T., Horikawa I., Barrett J.C., Schlegel R. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol. 75:(9):2001;4467-4472.
35. Vousden K.H., Lu X. Live or let die the cell's response to p53 . Nat. Rev. Cancer. 2:(8):2002;594-604.
36. Woodworth C.D., Cheng S., Simpson S., Hamacher L., Chow L.T., Broker T.R., Dipaolo J.A. Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene. 7:1992;19-626.
37. zur Hausen H. Viruses in human cancers. Science. 254:(5035):1991; 1167-1173.
38. zur Hausen H. Papillomaviruses causing cancer evasion from host-cell control in early events in carcinogenesis . J. Natl. Cancer Inst. 92:2000;690-698.